How mRNA COVID vaccines may help cancer patients live longer

Groundbreaking research reveals mRNA COVID-19 vaccines may significantly boost cancer immunotherapy success. Patients vaccinated within months of starting treatment showed a doubled survival rate after three years. This discovery suggests a powerful synergy, potentially transforming cancer care by enhancing the immune system’s fight against tumors, especially for those with previously resistant cancers.